Lead Product(s) : Temocillin Disodium
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Temocillin is a Antibiotic drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Urinary Tract Infections.
Product Name : Undisclosed
Product Type : Antibiotic
Upfront Cash : Inapplicable
March 05, 2012
Lead Product(s) : Temocillin Disodium
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
